Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05662_nanopub.RAC2CD46bPrAMLmArjsQxIHC5dUFDSaJlD-t34Zg6G46Y#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05662 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05662 label "NP-50301 [drugbank:DB05662]" assertion.
- drugbank:DB05662 seeAlso DB05662 assertion.
- drugbank:DB05662 description "NP-50301 is an ophthalmic therapeutic eye drop treating post-menopausal Dry Eye Syndrome (DES). It is being developed by Nascent Pharmaceuticals. It is estimated that about 30% of postmenopausal women suffer symptoms of DES, which accounts for over 12 million women in the U.S. The majority of sufferers of DES are postmenopausal women; and clinical research around the world has suggested the benefits of both topical and systemic estrogen therapy in the treatment of DES in this population." assertion.
- drugbank:DB05662 identifier "drugbank:DB05662" assertion.
- drugbank:DB05662 title "NP-50301" assertion.
- drugbank:DB05662 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05662 drugbank_vocabulary:drugbank-id "DB05662" assertion.
- drugbank:DB05662 bio2rdf_vocabulary:x-identifiers.org DB05662 assertion.
- drugbank:DB05662 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05662" assertion.
- drugbank:DB05662 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05662 bio2rdf_vocabulary:identifier "DB05662" assertion.